Search Clinical Trials

Search results for All Clinical Studies.

Found 352 clinical studies.

• Ea5182-

  • Investigator: Muhammad Riaz
  • Posted Date: May 13, 2021
  • Type of Study: Drug

• S1712- A Randomized Phase II Study Of Ruxolitinib (Nsc-752295) In Combination With Bcr-Abl Tyrosine Kinase Inhibitors In Chronic Myeloid Leukemia (Cml) Patients With Molecular Evidence Of Disease

  • Investigator: Emily Curran
  • Posted Date: May 13, 2021
  • Type of Study: Drug

• Tak-981-1501- Phase 1/2 Study Of Tak-981 In Combination With Rituximab In Patients With Relapsed/Refractory Cd20-Positive Non-Hodgkin Lymphoma

  • Investigator: Emily Curran
  • Posted Date: May 7, 2021
  • Type of Study: Drug

• Br-101801-Ct-101- A Phase I, Open-Label, Multi-Center, Dose Escalation, And Expansion Study Of Br101801 In Adult Patients With Advanced Hematologic Malignancies

  • Investigator: Emily Curran
  • Posted Date: May 7, 2021
  • Type of Study: Drug

• Survey Of United States Attending Surgeons On Audio Video Recording Practices

  • Investigator: Lane Frasier
  • Posted Date: May 7, 2021
  • Type of Study: Observational/Survey

• S1905- A Phase II Study Of Akr1c3-Activated Prodrug Obi-3424 (Obi-3424) In Patients With Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia (T-All)

  • Investigator: Emily Curran
  • Posted Date: May 7, 2021
  • Type of Study: Drug

• Vtx-2337-Hn-001- A Phase 1B Multicenter Pre-Surgical Study To Evaluate Immune Biomarker Modulation In Response To Motolimod (Vtx-2337) In Combination With Nivolumab In Subjects With Resectable Squamous Cell Carcinoma Of The Head And Neck (Scchn)

  • Investigator: Alice Tang
  • Posted Date: May 6, 2021
  • Type of Study: Drug

• Sym021-02- An Exploratory, Open-Label, Multicenter Phase 1B Trial To Evaluate Safety And Efficacy Of Sym021 (Anti-Pd-1) In Combination With Either Sym022 (Anti-Lag-3) Or Sym023 (Anti-Tim-3) In Patients With Advanced Solid Tumor Malignancies

  • Investigator: Shuchi Gulati
  • Posted Date: May 6, 2021
  • Type of Study: Drug

• Ezh-108- A Phase I, Open-Label Multi-Dose Two-Part Study To Characterize The Effects Of A Strong Cyp3a4 Inhibitor And A Strong Cyp3a4 Inducer On The Steady-State Pharmacokinetics Of Tazemetostat (Epz-6438) In Subjects With Advanced Malignancies

  • Investigator: Trisha Wise-Draper
  • Posted Date: May 6, 2021
  • Type of Study: Drug

• Abt-C6-2017- A Randomized Phase I/II Open Label Study To Assess The Efficacy And Safety Of Abtl0812 In Combination With Gemcitabine And Nab-Paclitaxel In Patients With Advanced Metastatic Pancreatic Cancer At First Line Therapy

  • Investigator: Davendra Sohal
  • Posted Date: May 6, 2021
  • Type of Study: Drug

• Uccc-Gi-20-02

  • Investigator: Davendra Sohal
  • Posted Date: May 6, 2021
  • Type of Study: Drug

• Uccc-Gi-20-01- Feasibility Of Total Neoadjuvant Therapy In Resectable Biliary Adenocarcinoma

  • Investigator: Jordan Kharofa
  • Posted Date: May 6, 2021
  • Type of Study: Drug

• S1931-Phase III Trial Of Immunotherapy-Based Combination Therapy With Or Without Cytoreductive Nephrectomy For Metastatic Renal Cell Carcinoma (Probe Trial)

  • Investigator: Shuchi Gulati
  • Posted Date: May 5, 2021
  • Type of Study: Drug

• Mk-7902-009-A Phase 2, Randomized, Open-Label Three-Arm Clinical Study To Evaluate The Safety And Efficacy Of Lenvatinib (E7080/Mk-7902) In Combination With Pembrolizumab (Mk-3475) Versus Standard Of Care Chemotherapy And Lenvatinib Monotherapy In Partici

  • Investigator: Muhammad Riaz
  • Posted Date: May 5, 2021
  • Type of Study: Drug

• Ms200647_0046- Safety Study Of Bintrafusp Alfa In Combination With Other Anti-Cancer Therapies In Participants With Locally Advanced Or Advanced Cervical Cancer

  • Investigator: Amanda Jackson
  • Posted Date: May 5, 2021
  • Type of Study: Drug

• Debio1143-Scchn-301- A Randomized, Double-Blind Placebo-Controlled, Phase 3 Study Of Debio 1143 In Combination With Platinum-Based Chemotherapy And Standard Fractionation Intensity-Modulated Radiotherapy In Patients With Locally Advanced Squamous Cell Car

  • Investigator: Trisha Wise-Draper
  • Posted Date: May 5, 2021
  • Type of Study: Drug

• Nrg-Hn007-An Open-Label, Phase III Study Of Platinum-Gemcitabine With Or Without Nivolumab In The First-Line Treatment Of Recurrent Or Metastatic Nasopharyngeal Carcinoma

  • Investigator: Muhammad Riaz
  • Posted Date: May 5, 2021
  • Type of Study: Drug

• Uccc-Hn-20-01- Phase 1B/II Trial Combining Pd1 Inhibition (Pembrolizumab) And Cesium 131 Brachytherapy With Salvage Surgery To Enhance Immunogenicity And Improve Local Control In Head And Neck Cancer

  • Investigator: Shuchi Gulati
  • Posted Date: May 5, 2021
  • Type of Study: Device & Drug

• Tumor-Agnostic Precision Immunooncology And Somatic Targeting Rational For You (Tapistry) Phase II Platform Trial

  • Investigator: Davendra Sohal
  • Posted Date: May 5, 2021
  • Type of Study: Drug

• A Dose Selection Trial Of Light Therapy For Impaired Sleep In Parkinson’S Disease

  • Investigator: Alberto Espay
  • Posted Date: Apr 30, 2021
  • Type of Study: Device

• Phase 3 Open-Label Extension Study Of Td-9855 For Treating Symptomatic Noh In Subjects With Primary Autonomic Failure (Oak)

  • Investigator: Alberto Espay
  • Posted Date: Apr 30, 2021
  • Type of Study: Drug

• Phase 3 Clinical Effect Durability Of Td-9855 For Treating Symptomatic Noh In Subjects With Primary Autonomic Failure (Redwood)

  • Investigator: Alberto Espay
  • Posted Date: Apr 30, 2021
  • Type of Study: Drug

• Ppmi 2.0 Clinical -Establishing A Deeply Phenotyped Pd Cohort

  • Investigator: Alberto Espay
  • Posted Date: Apr 30, 2021
  • Type of Study: Observational/Survey

• Trial Of Parkinson’S And Zoledronic Acid

  • Investigator: Alberto Espay
  • Posted Date: Apr 30, 2021
  • Type of Study: Drug

• The Dystonia Coalition Natural History And Biospecimen Repository For Isolated Dystonias (Dcp)

  • Investigator: Alberto Espay
  • Posted Date: Apr 30, 2021
  • Type of Study: Observational/Survey

• Pridopidine's Outcome On Function In Huntington Disease, Proof- Hd

  • Investigator: Andrew Duker
  • Posted Date: Apr 30, 2021
  • Type of Study: Drug

• Ca209-73L- A Phase 3, Randomized, Open Label Study To Compare Nivolumab Plus Concurrent Chemoradiotherapy (Ccrt) Followed By Nivolumab Plus Ipilimumab Or Nivolumab Plus Ccrt Followed By Nivolumab Vs Ccrt Followed By Durvalumab In Previously Untreated, Loc

  • Investigator: Emily Daugherty
  • Posted Date: Apr 28, 2021
  • Type of Study: Drug

• Iov-Lun-202- A Phase 2 Multicenter Study Of Autologous Tumor Infiltrating Lymphocytes (Ln-145) In Patients With Metastatic Non-Small-Cell Lung Cancer

  • Investigator: Trisha Wise-Draper
  • Posted Date: Apr 28, 2021
  • Type of Study: Drug

• D4194c00008- Prospective, Interventional Pilot Study Of Mobile Devices And Digital Applications To Detect Early Pneumonitis And Other Pulmonary Adverse Events In Unresectable Stage III Non-Small Cell Lung Cancer Patients On Durvalumab

  • Investigator: Muhammad Riaz
  • Posted Date: Apr 28, 2021
  • Type of Study: Observational/Survey

• Ecog Multiple Myeloma Equate Trial (Eaa181)

  • Investigator: Bryan Hambley
  • Posted Date: Apr 20, 2021
  • Type of Study: Drug

• Intravitreal Anti-Vegf For The Treatment Of Choroidal Neovascularization Secondary To Ocular Histoplasmosis: A Ten-Year Follow-Up

  • Investigator: Carl Noble
  • Posted Date: Apr 20, 2021
  • Type of Study: Observational/Survey

• Evaluation Of Cardiovascular And Bleeding Outcomes Post Percutaneous Coronary Intervention In Patients Undergoing Liver Transplant Evaluation

  • Investigator: Ahmed Souka
  • Posted Date: Mar 31, 2021
  • Type of Study: Observational/Survey

• Arena Ulcerative Colitis Study

  • Investigator: Loren Brook
  • Posted Date: Mar 31, 2021
  • Type of Study: Drug

• Urirox-2 Study For Patients With Kidney Stones And An Underlying Enteric Condition.

  • Investigator: Shashi Kant
  • Posted Date: Mar 30, 2021
  • Type of Study: Drug

• Podo Study For Focal Segmental Glomerulosclerosis (Fsgs)

  • Investigator: Amit Govil
  • Posted Date: Mar 30, 2021
  • Type of Study: Drug

• A Phase 2 Study Evaluating The Safety And Efficacy Of A Human Immunoglobulin Monoclonal Antibody That Targets The Hcmv Glycoprotein B In Cmv Negative Recipients (R-) Receiving Their First Solid Organ Transplant From Cmv Positive Donors (D+)

  • Investigator: Rita Alloway
  • Posted Date: Mar 29, 2021
  • Type of Study: Drug

• Outcomes Of A First Generation Support Network For Undergraduate Pre-Professional Students

  • Investigator: Demetria Fischesser
  • Posted Date: Mar 22, 2021
  • Type of Study: Observational/Survey

• An Open-Label, Multicenter Phase 4 Study To Assess Disease Activity And Biomarkers Of Neuronal Damage In Minority Patients With Relapsing Multiple Sclerosis Receiving Treatment With Ocrelizumab

  • Investigator: Lawrence Goldstick
  • Posted Date: Mar 19, 2021
  • Type of Study: Drug

• The Utility Of A Pre-Treatment Glomerular Filtration Rate (Gfr) Study In Radiotherapy Planning For High-Risk Neuroblastoma

  • Investigator: Andrew Frankart
  • Posted Date: Mar 8, 2021
  • Type of Study: Observational/Survey

• A Phase 2, Randomized, Placebo-Controlled Study To Evaluate Safety, Tolerability, And Efficacy Of Tak-079 In Patients With Generalized Myasthenia Gravis

  • Investigator: Hani Kushlaf
  • Posted Date: Mar 5, 2021
  • Type of Study: Drug

• Viela Bio A Randomized, Double-Blind, Multicenter,Placebo-Controlled Phase 3 Study With Open-Label Period To Evaluate The Efficacy And Safety Of Inebilizumab In Adults With Myasthenia Gravis

  • Investigator: Hani Kushlaf
  • Posted Date: Mar 5, 2021
  • Type of Study: Drug

• Implanet Jazz System

  • Investigator: Rani Nasser
  • Posted Date: Mar 3, 2021
  • Type of Study: Observational/Survey

• Tops (Total Posterior Spine System)

  • Investigator: Joseph Cheng
  • Posted Date: Mar 3, 2021
  • Type of Study: Device

• Allovir For Kidney Transplant Patients With Bk Virus

  • Investigator: Ervin Steve Woodle
  • Posted Date: Mar 1, 2021
  • Type of Study: Drug

• Clinical Trial Of Etrasimod In Adult Subjects With Eosinophilic Esophagitis

  • Investigator: Vidhya Kunnathur
  • Posted Date: Feb 23, 2021
  • Type of Study: Drug

• Artios Novartis Omb157g23101

  • Investigator: Aram Zabeti
  • Posted Date: Feb 15, 2021
  • Type of Study: Drug

• Bn42083 A Phase IIIb Multicenter, Randomized, Double-Blind, Controlled Study To Evaluate The Efficacy, Safety And Pharmacokinetics Of A Higher Dose Of Ocrelizumab In Adults With Primary Progressive Multiple Sclerosis

  • Investigator: Aram Zabeti
  • Posted Date: Feb 15, 2021
  • Type of Study: Drug

• Sunbeam (Systems Biology Of Early Atopy): A Mother- Infant Cohort Study

  • Investigator: Emily Defranco
  • Posted Date: Feb 12, 2021
  • Type of Study: Observational/Survey

• The Role Of The Circadian System In Binge Eating Disorder

  • Investigator: Francisco Romo-Nava
  • Posted Date: Feb 4, 2021
  • Type of Study: Device & Drug

• Screening Study To Identify Patients At Risk For Cardiac Amyloidosis

  • Investigator: Robert O'donnell
  • Posted Date: Feb 1, 2021
  • Type of Study: Observational/Survey

• A Phase 3, Open-Label, 1-Year Study Of The Safety, Tolerability, And Need For Re-Treatment With Sage-217 In Adult Subjects With Major Depressive Disorder

  • Investigator: Caleb Adler
  • Posted Date: Jan 25, 2021
  • Type of Study: Drug

• Effects Of Plasma Exchange On Adolescent And Adult Patients With Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infections (Pandas)

  • Investigator: Caroline Alquist
  • Posted Date: Jan 21, 2021
  • Type of Study: Observational/Survey

• Social Media In The Virtual Interview Residency Cycle

  • Investigator: Jaime Lewis
  • Posted Date: Jan 20, 2021
  • Type of Study: Observational/Survey

• Incb57643-103- A Phase 1, Open-Label, Safety And Tolerability Study Of Incb057643 In Participants With Myelofibrosis

  • Investigator: Emily Curran
  • Posted Date: Jan 18, 2021
  • Type of Study: Drug

• R1216- Randomized Phase II/III Trial Of Adjuvant Radiation Therapy With Cisplatin, Docetaxel-Cetuximab, Or Cisplatin-Atezolizumab In Pathologic High-Risk Squamous Cell Cancer Of The Head And Neck

  • Investigator: Sara Medek
  • Posted Date: Jan 18, 2021
  • Type of Study: Drug

• A041501- A Phase III Trial To Evaluate The Efficacy Of The Addition Of Inotuzumab Ozogamicin (A Conjugated Anti-Cd22 Monoclonal Antibody) To Frontline Therapy In Young Adults (Ages 18-39 Years) With Newly Diagnosed Precursor B-Cell All

  • Investigator: Emily Curran
  • Posted Date: Jan 18, 2021
  • Type of Study: Drug

• Uccc-Hn-20-02- Evaluation Of Complicated Living Grief In Head And Neck Cancer Patients And Survivors

  • Investigator: Chad Zender
  • Posted Date: Jan 18, 2021
  • Type of Study: Observational/Survey

• A031702- A Phase II Study Of Ipilimumab , Cabozantinib, And Nivolumab In Rare Genitourinary Cancers (Iconic)

  • Investigator: Shuchi Gulati
  • Posted Date: Jan 18, 2021
  • Type of Study: Drug

• Sl03-Ohd-102- Phase 1 Dose Escalation Study Of The Agonist Redirected Checkpoint, Sl-172154 (Sirpα-Fc-Cd40l), Administered Intratumorally In Subjects With Cutaneous Squamous Cell Carcinoma Or Squamous Cell Carcinoma Of The Head And Neck

  • Investigator: Trisha Wise-Draper
  • Posted Date: Jan 18, 2021
  • Type of Study: Drug

• A Phase 3, Randomized, Double-Blind Study Comparing The Efficacy And Safety Of Sage-217 Plus An Antidepressant Versus Placebo Plus An Antidepressant In Adults With Major Depressive Disorder

  • Investigator: Caleb Adler
  • Posted Date: Jan 6, 2021
  • Type of Study: Drug

• A Trial Of Transplanting Hepatitis C Kidneys Into Hepatitis C Negative Kidney Recipients

  • Investigator: Rita Alloway
  • Posted Date: Jan 5, 2021
  • Type of Study: Drug

• Recurrent Respiratory Papillomatosis (Rrp) Treatment With A Dna Vaccine

  • Investigator: Aaron Friedman
  • Posted Date: Dec 22, 2020
  • Type of Study: Device & Drug

• Pre0905- Randomized Trial Of Gilteritinib Vs Midostaurin In Flt3 Mutated Acute Myeloid Leukemia (Aml)

  • Investigator: Emily Curran
  • Posted Date: Dec 19, 2020
  • Type of Study: Drug

• Morab-202-G000-201- A Phase II Study Of Ipilimumab, Cabozantinib, And Nivolumab In Rare Genitourinary Cancers (Iconic)

  • Investigator: Muhammad Riaz
  • Posted Date: Dec 17, 2020
  • Type of Study: Drug

• Fgcl-3019-087- A Phase 3, Randomized, Double-Blind Study Of Pamrevlumab Or Placebo In Combination With Gemcitabine Plus Nab-Paclitaxel (G/Np) As Neoadjuvant Treatment In Patients With Locally Advanced, Unresectable Pancreatic Cance

  • Investigator: Davendra Sohal
  • Posted Date: Dec 17, 2020
  • Type of Study: Drug

• Epigenetic Signature Of Prenatal Opioid Exposure

  • Investigator: Brittany Smith
  • Posted Date: Dec 14, 2020
  • Type of Study: Observational/Survey

• Iov-Com-202- A Phase 2, Multicenter Study Of Autologous Tumor Infiltrating Lymphocytes (Ln 144/Ln-145/Ln-145-S1) In Patients With Solid Tumors

  • Investigator: Trisha Wise-Draper
  • Posted Date: Nov 28, 2020
  • Type of Study: Drug

• S1820- A Randomized Trial Of The Altering Intake, Managing Symptoms Intervention For Bowel Dysfunction In Rectal Cancer Survivors Compared To A Healthy Living Education Control: A Feasibility And Preliminary Efficacy Study (Aims-Rc)

  • Investigator: Jordan Kharofa
  • Posted Date: Nov 28, 2020
  • Type of Study: Observational/Survey

• A041703- A Phase II Study Of Inotuzumab Ozogamicin Followed By Blinatumomab For Ph-Negative Cd22-Positive B-Lineage Acute Lymphoblastic Leukemia In Newly Diagnosed Older Adults Or Adults With Relapsed Or Refractory Diseas

  • Investigator: Emily Curran
  • Posted Date: Nov 28, 2020
  • Type of Study: Drug

• Uccc-Hn-19-03- An Open-Label, Phase II Study Evaluating The Efficacy Of Niraparib And Dostarlimab (Tsr-042) In Recurrent/Metastatic Head And Neck Squamous Cell Carcinoma Patients

  • Investigator: Trisha Wise-Draper
  • Posted Date: Nov 24, 2020
  • Type of Study: Drug

• Mk-3475-937- A Phase 3 Double-Blinded, Two-Arm Study To Evaluate The Safety And Efficacy Of Pembrolizumab (Mk-3475) Versus Placebo As Adjuvant Therapy In Participants With Hepatocellular Carcinoma And Complete Radiological Response After Surgical Resectio

  • Investigator: Davendra Sohal
  • Posted Date: Nov 24, 2020
  • Type of Study: Drug

• Lae002int2001- An Open-Label Randomized Active-Controlled Phase II Clinical Study To Assess The Efficacy And Safety Of Afuresertib Plus Paclitaxel Versus Paclitaxel In Patients With Platinum-Resistant Ovarian Cancer

  • Investigator: Thomas Herzog
  • Posted Date: Nov 24, 2020
  • Type of Study: Drug

• Use Of Benralizumab For Patients With Moderate To Severe Atopic Dermatitis Despite Treatment With Topical Medications

  • Investigator: Debra Breneman
  • Posted Date: Nov 17, 2020
  • Type of Study: Drug

• A Phase IIIb Multicenter, Randomized, Double-Blind, Controlled Study To Evaluate The Efficacy, Safety And Pharmacokinetics Of A Higher Dose Of Ocrelizumab In Adults With Relapsing Multiple Sclerosis

  • Investigator: Lawrence Goldstick
  • Posted Date: Oct 29, 2020
  • Type of Study: Drug

• A Phase 3, Randomized, Double-Blind, Efficacy And Safety Study Comparing Sar442168 To Placebo In Participants With Nonrelapsing Secondary Progressive Multiple Sclerosis (Hercules)

  • Investigator: Lawrence Goldstick
  • Posted Date: Oct 27, 2020
  • Type of Study: Drug

• Nrg-Gi005- Phase II/III Study Of Circulating Tumor Dna As A Predictive Biomarker In Adjuvant Chemotherapy In Patients With Stage IIa Colon Cancer (Cobra)

  • Investigator: Davendra Sohal
  • Posted Date: Oct 26, 2020
  • Type of Study: Drug

• Uccc-Hn-19-01

  • Investigator: Trisha Wise-Draper
  • Posted Date: Oct 26, 2020
  • Type of Study: Drug

• Gog-3031- A Phase 3, Randomized, Double-Blind, Multicenter Study Of Dostarlimab (Tsr-042) Plus Carboplatin-Paclitaxel Versus Placebo Plus Carboplatin-Paclitaxel In Patients With Recurrent Or Primary Advanced Endometrial Cancer (Ruby)

  • Investigator: Caroline Billingsley
  • Posted Date: Oct 26, 2020
  • Type of Study: Drug

• Ea3132- Phase II Randomized Trial Of Radiotherapy With Or Without Cisplatin For Surgically Resected Squamous Cell Carcinoma Of The Head And Neck (Scchn) With Tp53 Sequencing

  • Investigator: Trisha Wise-Draper
  • Posted Date: Oct 26, 2020
  • Type of Study: Drug

• Gn42272: A Phase III Randomized, Double-Blind Study To Evaluate Efficacy And Safety Of Fenebrutinib Compared With Teriflunomide In Patients With Relapsing Multiple Sclerosis

  • Investigator: Aram Zabeti
  • Posted Date: Oct 23, 2020
  • Type of Study: Drug

• Voice Quality Analysis In Recurrent Respiratory Papillomatosis (Rrp)

  • Investigator: Aaron Friedman
  • Posted Date: Oct 11, 2020
  • Type of Study: Observational/Survey

• "Smart-Fm": Smart-Phone Based Digital Therapeutic For Management Of Fibromyalgia

  • Investigator: Lesley Arnold
  • Posted Date: Oct 6, 2020
  • Type of Study: Device

• Optimal Timing Of Direct Acting Antivirals In Hepatitis C-Associated Hepatocellular Carcinoma

  • Investigator: Shimul Shah
  • Posted Date: Oct 5, 2020
  • Type of Study: Observational/Survey

• Ea6141- Phase II/III Trial Of Nivolumab, Ipilimumab, And Gm-Csf In Patients With Advanced Melanoma

  • Investigator: Rekha Chaudhary
  • Posted Date: Oct 5, 2020
  • Type of Study: Drug

• "A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Dose Escalation And Proof-Of-Concept Study To Evaluate The Safety And Efficacy Of Razuprotafib In Hospitalized Subjects With Moderate To Severe Coronavirus Disease 2019

  • Investigator: Richard Becker
  • Posted Date: Oct 2, 2020
  • Type of Study: Drug

• Pacific-4 Trial: Durvalumab Immunotherapy Versus Placebo With Stereotactic Body Radiation Therapy (Sbrt) In Early Stage, Unresected Non-Small Cell Lung Cancer Patients

  • Investigator: Emily Daugherty
  • Posted Date: Sep 28, 2020
  • Type of Study: Drug

• Nrg Lu-007: The Raptor Trial For Extensive Stage Small Cell Lung Cancer; Randomized Phase II/III Trial Of Consolidation Radiation + Immunotherapy For Es-Sclc

  • Investigator: Emily Daugherty
  • Posted Date: Sep 28, 2020
  • Type of Study: Device

• Law Enforcement Officer Opioid Exposure

  • Investigator: Kermit Davis
  • Posted Date: Sep 28, 2020
  • Type of Study: Observational/Survey

• Rtog-1308: Phase III Randomized Trial Comparing Overall Survival After Photon Versus Proton Chemoradiotherapy For Inoperable Stage II-IIIb Nsclc

  • Investigator: Emily Daugherty
  • Posted Date: Sep 28, 2020
  • Type of Study: Device

• Quantifying The Role Of Sensory Systems Processing In Post-Stroke Walking Recovery

  • Investigator: Oluwole Awosika
  • Posted Date: Sep 22, 2020
  • Type of Study: Observational/Survey

• Optimizing Training In Severe Post-Stroke Walking Impairment

  • Investigator: Oluwole Awosika
  • Posted Date: Sep 22, 2020
  • Type of Study: Observational/Survey

• Single Cell Rna Sequencing In Patients With Aggressive Subtypes Of Breast Cancer

  • Investigator: Jun-Lin Guan
  • Posted Date: Sep 21, 2020
  • Type of Study: Observational/Survey

• A Due

  • Investigator: Jean Elwing
  • Posted Date: Sep 15, 2020
  • Type of Study: Drug

• Obstetrical Complications Among Women Who Attended A Crisis Pregnancy Center

  • Investigator: Priya Gursahaney
  • Posted Date: Sep 14, 2020
  • Type of Study: Observational/Survey

• Equity Impact Of Covid-19 In Medical Education

  • Investigator: Heather Christensen
  • Posted Date: Sep 14, 2020
  • Type of Study: Observational/Survey

• Study In Parkinson's Disease Of Exercise Phase 3 Clinical Trial: Sparx3

  • Investigator: Alberto Espay
  • Posted Date: Sep 14, 2020
  • Type of Study: Observational/Survey

• Amgen 20190135 - A Phase 1B, Master Protocol Evaluating The Safety, Tolerability, Pharmacokinetics, And Efficacy Of Amg 510 In Subjects With Advanced Solid Tumors With Kras P.G12c Mutation

  • Investigator: Davendra Sohal
  • Posted Date: Sep 11, 2020
  • Type of Study: Drug

• Alliance A071801- Phase III Trial Of Post-Surgical Single Fraction Stereotactic Radiosurgery (Srs) Compared With Fractionated Srs (Fsrs) For Resected Metastatic Brain Disease

  • Investigator: Kyle Wang
  • Posted Date: Sep 11, 2020
  • Type of Study: Observational/Survey

• Uccc-Bn-19-01- Detecting Tumor-Derived Cell-Free Dna In Csf Of Glioblastoma Patients And Determining The Correlation To Tumor Burden And Prognosis

  • Investigator: Matthew Garrett
  • Posted Date: Sep 11, 2020
  • Type of Study: Observational/Survey

• Mek-Nf-201- A Phase 2B Trial Of The Mek 1/2 Inhibitor (Meki) Pd-0325901 In Adult And Pediatric Patients With Neurofibromatosis Type 1 (Nf1)-Associated Inoperable Plexiform Neurofibromas (Pns) That Are Causing Significant Morbidity

  • Investigator: Soma Sengupta
  • Posted Date: Sep 11, 2020
  • Type of Study: Drug

• A 4-Week Study In Subjects Aged 10 To 17 Years With Bipolar I Disorder

  • Investigator: Luis Patino Duran
  • Posted Date: Sep 9, 2020
  • Type of Study: Drug

• Gb002 In Adult Subjects With Pah

  • Investigator: Jean Elwing
  • Posted Date: Sep 8, 2020
  • Type of Study: Drug

• Gsk 2019N411039- Phase Ib Trial To Evaluate The Efficacy And Safety Of Bintrafusp Alfa (M7824) Monotherapy In Metastatic Or Locally Advanced/Unresectable Urothelial Cancer With Disease Progression Or Recurrence Following Treatment With A Platinum Agent

  • Investigator: Shuchi Gulati
  • Posted Date: Sep 7, 2020
  • Type of Study: Drug

• Bms Ca031-002- A Phase 1/2 First-In-Human Study Of Bms-986258 Alone And In Combination With Nivolumab In Advanced Malignant Tumors

  • Investigator: Davendra Sohal
  • Posted Date: Sep 7, 2020
  • Type of Study: Drug

• Nrg-Gy009

  • Investigator: Thomas Herzog
  • Posted Date: Sep 7, 2020
  • Type of Study: Drug

• Apexigen Apx005m-006- A Phase 2 Study Of Apx005m In Combination With Concurrent Chemoradiation As Neoadjuvant Therapy For Resectable Esophageal And Gastroesophageal Junction Cancers

  • Investigator: Davendra Sohal
  • Posted Date: Sep 4, 2020
  • Type of Study: Drug

• Mk7902-012- A Phase 3 Multicenter, Randomized, Double-Blinded, Active-Controlled, Clinical Study To Evaluate The Safety And Efficacy Of Lenvatinib (E7080/Mk-7902) With Pembrolizumab (Mk-3475) In Combination With Transarterial Chemoembolization (Tace) Vers

  • Investigator: Olugbenga Olowokure
  • Posted Date: Sep 4, 2020
  • Type of Study: Drug

• Pathology Of Mast Cell Disease

  • Investigator: Nives Zimmermann
  • Posted Date: Sep 2, 2020
  • Type of Study: Observational/Survey

• Maternal Morbidity After Expectant Management Of Previable Preterm Rupture Of Membranes

  • Investigator: Marianne Dinapoli
  • Posted Date: Sep 1, 2020
  • Type of Study: Observational/Survey

• Ncicovid- Nci Covid-19 In Cancer Patients Study (N-Ccaps): A Longitudinal Natural History Study

  • Investigator: Shuchi Gulati
  • Posted Date: Aug 31, 2020
  • Type of Study: Observational/Survey

• The Association Of Adverse Childhood Experiences And Social Determinants Of Health On Hiv States And Outcomes

  • Investigator: David Karol
  • Posted Date: Aug 27, 2020
  • Type of Study: Observational/Survey

• Preeclampsia Blood Collection Study

  • Investigator: Emily Defranco
  • Posted Date: Aug 26, 2020
  • Type of Study: Observational/Survey

• A Dynamic Functional Immune Assay To Evaluate The Immune Response Of A Patient With Diabetes And A Foot Infection

  • Investigator: Peter Crisologo
  • Posted Date: Aug 26, 2020
  • Type of Study: Observational/Survey

• Barriers And Facilitators To Prevention Of Cov1d-19 In Latinx Families

  • Investigator: Amy Rule
  • Posted Date: Aug 26, 2020
  • Type of Study: Observational/Survey

• Maverick Trial: Mri Brain Surveillance Alone Versus Mri Surveillance And Prophylactic Cranial Irradiation (Pci) - A Randomized Phase III Trial In Small-Cell Lung Cancer

  • Investigator: Emily Daugherty
  • Posted Date: Aug 26, 2020
  • Type of Study: Observational/Survey

• Qualitative Assessment Of Patient Perception Of Control And Exacerbation In Crs

  • Investigator: Ahmad Sedaghat
  • Posted Date: Aug 26, 2020
  • Type of Study: Observational/Survey

• A Phase III Multicenter, Randomized, Double-Blind, Double-Dummy, Parallel-Group Study To Evaluate The Efficacy And Safety Of Fenebrutinib Compared With Ocrelizumab In Adult Patients With Primary Progressive Multiple Sclerosis

  • Investigator: Aram Zabeti
  • Posted Date: Aug 25, 2020
  • Type of Study: Drug

• Erich-Gene

  • Investigator: Daniel Woo
  • Posted Date: Aug 25, 2020
  • Type of Study: Observational/Survey

• Mirati 849-01- A Phase 1/2 Multiple Expansion Cohort Trial Of Mrtx849 In Patients With Advanced Solid Tumors With Kras G12c Mutation

  • Investigator: Muhammad Riaz
  • Posted Date: Aug 5, 2020
  • Type of Study: Drug

• Cipher

  • Investigator: Jean Elwing
  • Posted Date: Jul 16, 2020
  • Type of Study: Observational/Survey

• Alkermes Alks4230-001- A Phase 1/2 Study Of Alks 4230 Administered Subcutaneously As Monotherapy And In Combination With Pembrolizumab In Subjects With Advanced Solid Tumors

  • Investigator: Trisha Wise-Draper
  • Posted Date: Jul 9, 2020
  • Type of Study: Drug

• Alliance A221702- A Prospective Trial To Study Rates Of Lymphedema And Regional Recurrence After Sentinel Lymph Node Biopsy And Sentinel Lymph Node Biopsy Followed By Axillary Lymph Node Dissection With And Without Axillary Reverse Mapping

  • Investigator: Elizabeth Shaughnessy
  • Posted Date: Jul 9, 2020
  • Type of Study: Observational/Survey

• Repiimune Rpl-002-18

  • Investigator: Rekha Chaudhary
  • Posted Date: Jul 8, 2020
  • Type of Study: Drug

• Ecog-Acrin Ea2182- A Randomized Phase II Study Of De-Intensified Chemoradiation For Early- Stage Anal Squamous Cell Carcinoma

  • Investigator: Jordan Kharofa
  • Posted Date: Jul 8, 2020
  • Type of Study: Drug

• Regeneron R2810-Onc-1788- A Randomized, Placebo-Controlled, Double-Blind Study Of Adjuvant Cemiplimab Versus Placebo After Surgery And Radiation Therapy In Patients With High Risk Cutaneous Squamous Cell Carcinoma

  • Investigator: Rekha Chaudhary
  • Posted Date: Jul 8, 2020
  • Type of Study: Drug

• Coronavirus Nomacopan Emergency Treatment For Covid 19 Infected Patients With Early Signs Of Respiratory Distress (Coronet 1)

  • Investigator: Jonathan Bernstein
  • Posted Date: Jun 29, 2020
  • Type of Study: Drug

• Understanding Stress Caused By Covid-19 Pandemic Among Home Healthcare Providers

  • Investigator: Kermit Davis
  • Posted Date: Jun 9, 2020
  • Type of Study: Observational/Survey

• Trailblazer (I5t-Mc-Aaci): Assessment Of Safety, Tolerability, And Efficacy Of Donanemab In Early Symptomatic Alzheimer’S Disease

  • Investigator: Lawrence Goldstick
  • Posted Date: Jun 9, 2020
  • Type of Study: Drug

• Recurrence After Robotic Hysterectomy For Cervical Cancer

  • Investigator: Amanda Jackson
  • Posted Date: Jun 5, 2020
  • Type of Study: Observational/Survey

• Alector Study

  • Investigator: Russell Sawyer
  • Posted Date: May 29, 2020
  • Type of Study: Drug

• Qbgj398-301- A Phase 3 Multicenter, Open-Label, Randomized, Controlled Study Of Oral Infigratinib Versus Gemcitabine With Cisplatin In Subjects With Advanced/Metastatic Or Inoperable Cholangiocarcinoma With Fgfr2 Gene Fusions/Translocations: The Proof Tri

  • Investigator: Olugbenga Olowokure
  • Posted Date: May 22, 2020
  • Type of Study: Drug

• Swog S1806 Phase III Randomized Trial Of Concurrent Chemoradiotherapy With Or Without Atezolizumab In Localized Muscle Invasive Bladder Cancer

  • Investigator: Abhinav Sidana
  • Posted Date: May 22, 2020
  • Type of Study: Drug

• Alliance A031704- Pd-Inhibitor (Nivolumab) And Ipilimumab Followed By Nivolumab Vs. Vegf Tki Cabozantinib With Nivolumab: A Phase III Trial In Metastatic Untreated Renal Cell Cancer [Pdigree]

  • Investigator: Shuchi Gulati
  • Posted Date: May 22, 2020
  • Type of Study: Drug

• Keychain- Phase II Randomized Trial Of Radiotherapy With Concurrent And Adjuvant Pembrolizumab (Keytruda®) Versus Concurrent Chemotherapy In Patients With Advanced/Intermediate-Risk P16+ Head And Neck Squamous Cell Carcinoma

  • Investigator: Trisha Wise-Draper
  • Posted Date: Apr 23, 2020
  • Type of Study: Drug

• S1826- A Phase III, Randomized Study Of Nivolumab (Opdivo) Plus Avd Or Brentuximab Vedotin (Adcetris) Plus Avd In Patients (Age >/= 12 Years) With Newly Diagnosed Advanced Stage Classical Hodgkin Lymphoma

  • Investigator: Tahir Latif
  • Posted Date: Apr 23, 2020
  • Type of Study: Drug

• Hyperpolarized 129-Xe Magnetic Resonance Imaging For Lung Disease - Pediatric Asthma

  • Investigator: Nancy Lin
  • Posted Date: Apr 20, 2020
  • Type of Study: Device & Drug

• Ehr-Embedded Decision Support To Prevent Stroke In Patients With Af

  • Investigator: Mark Eckman
  • Posted Date: Apr 1, 2020
  • Type of Study: Observational/Survey

• Cincinnati Cohort Biomarkers Program

  • Investigator: Alberto Espay
  • Posted Date: Mar 16, 2020
  • Type of Study: Observational/Survey

• Ea4181- A Randomized 3-Arm Phase II Study Comparing 1.) Bendamustine, Rituximab And High Dose Cytarabine (Br/Cr) 2.) Bendamustine, Rituximab, High Dose Cytarabine And Acalabrutinib (Br/Cr-A), And 3.) Bendamustine, Rituximab And Acalabrutinib (Br-A) In Pat

  • Investigator: Tahir Latif
  • Posted Date: Mar 11, 2020
  • Type of Study: Observational/Survey

• Fviia For Acute Hemorrhagic Stroke Administered At Earliest Time (Fastest) Trial

  • Investigator: Kyle Walsh
  • Posted Date: Mar 9, 2020
  • Type of Study: Drug

• Nrg-Gy018- A Phase III Randomized, Placebo-Controlled Study Of Pembrolizumab (Mk-3475, Nsc #776864) In Addition To Paclitaxel And Carboplatin For Measurable Stage III Or Iva, Stage Ivb Or Recurrent Endometrial Cancerchemoradiation Plus Atezolizumab

  • Investigator: Amanda Jackson
  • Posted Date: Mar 6, 2020
  • Type of Study: Drug

• J2g-Mc-Jzjb- A Multicenter, Randomized, Open-Label, Phase 3 Trial Comparing Loxo-292 To Physicians Choice Of Cabozantinib Or Vandetanib In Patients With Progressive, Advanced, Kinase Inhibitor Naïve, Ret-Mutant Medullary Thyroid Cancer

  • Investigator: Trisha Wise-Draper
  • Posted Date: Mar 4, 2020
  • Type of Study: Drug

• Ea4151-A Randomized Phase III Trial Of Consolidation With Autologous Hematopoietic Cell Transplantation Followed By Maintenance Rituximab Vs. Maintenance Rituximab Alone For Patients With Mantle Cell Lymphoma In Minimal Residual Disease-Negative First Com

  • Investigator: Tahir Latif
  • Posted Date: Mar 4, 2020
  • Type of Study: Drug

• Alliance A021703- Randomized Double-Blind Phase III Trial Of Vitamin D3 Supplementation In Patients With Previously Untreated Metastatic Colorectal Cancer

  • Investigator: Tahir Latif
  • Posted Date: Feb 27, 2020
  • Type of Study: Drug

• Nrg-Gy022- Assessment Of Carboplatin Clearance Predictors: A Pk Study On Nci-Sponsored Clinical Trials Or Standard Of Care Treatments Using Carboplatin

  • Investigator: Trisha Wise-Draper
  • Posted Date: Feb 27, 2020
  • Type of Study: Observational/Survey

• Ca030-001- A Phase 1/2 First-In-Human Study Of Bms-986249 Alone And In Combination With Nivolumab

  • Investigator: Trisha Wise-Draper
  • Posted Date: Feb 26, 2020
  • Type of Study: Drug

• Effect Of Tefillin (Phylacteries) On Changes In Heart Rate In Healthy People

  • Investigator: Jack Rubinstein
  • Posted Date: Feb 26, 2020
  • Type of Study: Device

• Ngm18-0402- A Phase 1A/B Dose-Escalation Study Followed By Expansion Cohorts Of Ngm120, A Gfral Antagonist Monoclonal Antibody Blocking Gdf15 Signaling, In Subjects With Advanced Solid Tumors And Pancreatic Cancer Using Combination Therapy

  • Investigator: Shuchi Gulati
  • Posted Date: Feb 24, 2020
  • Type of Study: Drug

• Oncg100- A Phase 2, Multicenter Open-Label, Non-Randomized Study Of Bavituximab Plus Pembrolizumab In Patients With Advanced Gastric Or Gastroesophageal Cancer Who Have Progressed On Or After At Least One Prior Standard Therapy

  • Investigator: Olugbenga Olowokure
  • Posted Date: Feb 24, 2020
  • Type of Study: Drug

• Pathophysiology Of Medically Managed Inflammatory Sinonasal Disease

  • Investigator: Ahmad Sedaghat
  • Posted Date: Feb 6, 2020
  • Type of Study: Observational/Survey

• This Research Study Will Investigate A Study Medication And Its Therapeutic Effects In Patients Who Have Fibromyalgia.

  • Investigator: Lesley Arnold
  • Posted Date: Feb 6, 2020
  • Type of Study: Drug

• Ucci-Gi-18-01- Echo Decorrelation Imaging During Standard Clinical Radiofrequency Ablation And Microwave Ablation Of Liver Cancer

  • Investigator: Truman Douglas Mast
  • Posted Date: Feb 5, 2020
  • Type of Study: Observational/Survey

• Nrg Lu-003: A Biomarker Driven Protocol For Previously Treated Alk-Mutation Positive Non-Squamous, Non-Small Cell Lung Cancer - A Nci-Nrg Alk Master Protocol

  • Investigator: Emily Daugherty
  • Posted Date: Feb 5, 2020
  • Type of Study: Drug

• Nrg Lu-005: A Phase II/III Randomized Study Of Chemoradiation Versus Chemoradiation Plus Atezolizumab Immunotherapy In Limited Stage Small Cell Lung Cancer (Ls-Sclc)

  • Investigator: Emily Daugherty
  • Posted Date: Feb 5, 2020
  • Type of Study: Drug

• In This Study, Doctors Want To Evaluate The Safety And Effectiveness Of An Investigational Drug In Patients With Attenuated Psychosis Syndrome.

  • Investigator: Caleb Adler
  • Posted Date: Jan 28, 2020
  • Type of Study: Drug

• An Adult And Adolescent Schizophrenia Study To Evaluate The Effects Of Extended Release Injectable

  • Investigator: Caleb Adler
  • Posted Date: Jan 28, 2020
  • Type of Study: Drug

• This Study Will Look At The Safety Of Sodium Benzoate, And At How Well It Works In Improving Symptoms Of Schizophrenia When Added To Current Medication

  • Investigator: Caleb Adler
  • Posted Date: Jan 28, 2020
  • Type of Study: Drug

• A Study To Evaluate An Oral Investigational Drug To See If It Helps Treat Symptoms In Adults With Adhd.

  • Investigator: Caleb Adler
  • Posted Date: Jan 27, 2020
  • Type of Study: Drug

• An Adult And Adolescent Schizophrenia Study To Evaluate The Effects Of Extended Release Injectable

  • Investigator: Caleb Adler
  • Posted Date: Jan 27, 2020
  • Type of Study: Drug

• A Long Term Study To Evaluate An Oral Investigational Drug To See If It Helps Treat Symptoms In Adults With Adhd.

  • Investigator: Caleb Adler
  • Posted Date: Jan 27, 2020
  • Type of Study: Drug

• Prospective Study Tracking Chronic Rhinosinusitis Symptoms On Phone App

  • Investigator: Katie Phillips
  • Posted Date: Jan 24, 2020
  • Type of Study: Observational/Survey

• Effect Of Fasting On Insulin-Induced Hypoglycemia Counterregulation In Individuals With Type 1 Diabetes

  • Investigator: Jason Winnick
  • Posted Date: Jan 23, 2020
  • Type of Study: Drug

• Neuroscience Retrospective Chart Review

  • Investigator: Daniel Woo
  • Posted Date: Jan 23, 2020
  • Type of Study: Observational/Survey

• Mechanism Of Antidepressant-Related Dysfunctional Arousal In High-Risk Youth

  • Investigator: Melissa Delbello
  • Posted Date: Jan 14, 2020
  • Type of Study: Drug

• A Study To Evaluate Nyx-458 In Subjects With Mild Cognitive Impairment Associated With Parkinson's Disease

  • Investigator: Michael Keys
  • Posted Date: Jan 14, 2020
  • Type of Study: Drug

• Long-Term, Open-Label, Flexible-Dose, Extension Study Of Vortioxetine In Child And Adolescent Patients With Major Depressive Disorder (Mdd)

  • Investigator: Melissa Delbello
  • Posted Date: Jan 14, 2020
  • Type of Study: Drug

• Study Designed To Evaluate The Long-Term Safety And Efficacy Of Study Drug (Spd503) In Kids With Attention-Deficit/Hyperactivity Disorder

  • Investigator: Melissa Delbello
  • Posted Date: Jan 14, 2020
  • Type of Study: Drug

• Debio 1143-106- A Smac Mimetic In Combination With Nivolumab In Patients Failing Prior Pd-1/Pd-L1 Treatment

  • Investigator: Shuchi Gulati
  • Posted Date: Dec 30, 2019
  • Type of Study: Drug

• Chemoid Cg03-Eoc- Standard Chemotherapy Versus Cancer Stem Cell Assay Directed Chemotherapy In Recurrent Platinum Resistant Ovarian Cancer

  • Investigator: Thomas Herzog
  • Posted Date: Dec 30, 2019
  • Type of Study: Drug

• Gender Differences, Defect Reversibility, And Imaging Position: Importance For Diagnosis Of Coronary Artery Disease Using A Cadmium-Zinc-Telluride Nuclear Cardiology Camera

  • Investigator: Myron Gerson
  • Posted Date: Dec 24, 2019
  • Type of Study: Device

• Consent For Application Of Vortexpap To Continuous Positive Airway Pressure (Cpap) Therapy

  • Investigator: Liran Oren
  • Posted Date: Dec 17, 2019
  • Type of Study: Device

• Biologics In Allergic Disease: Biologics For Asthma

  • Investigator: Jonathan Bernstein
  • Posted Date: Dec 7, 2019
  • Type of Study: Observational/Survey

• Bariatric Surgery Improving Surgical Outcomes, Our Experience And Future Direction

  • Investigator: Michael Johnston
  • Posted Date: Dec 5, 2019
  • Type of Study: Observational/Survey

• Rv Abnormalities In Spect Imaging

  • Investigator: Arun Jose
  • Posted Date: Dec 4, 2019
  • Type of Study: Observational/Survey

• Child Study For Tourette’S Disorder

  • Investigator: Jeffrey Strawn
  • Posted Date: Nov 22, 2019
  • Type of Study: Drug

• Child Study For Major Depressive Disorder

  • Investigator: Jeffrey Strawn
  • Posted Date: Nov 22, 2019
  • Type of Study: Drug

• Child And Adolescent Generalized Anxiety Disorder Study

  • Investigator: Jeffrey Strawn
  • Posted Date: Nov 22, 2019
  • Type of Study: Drug

• Adults Struggling With Anxiety In The Form Of One Or More Of The Following Diagnoses: Generalized Anxiety Disorder, Separation Anxiety Disorder, Social Anxiety Disorder And/Or Panic Disorder.

  • Investigator: Jeffrey Strawn
  • Posted Date: Nov 22, 2019
  • Type of Study: Drug

• Child Study For The Treatment Of Anxiety Disorders.

  • Investigator: Jeffrey Strawn
  • Posted Date: Nov 22, 2019
  • Type of Study: Drug

• Adolescent Schizophrenia Study

  • Investigator: Luis Patino Duran
  • Posted Date: Nov 21, 2019
  • Type of Study: Drug

• Long-Term Antipsychotic Pediatric Safety Trial (Laps)

  • Investigator: Luis Patino Duran
  • Posted Date: Nov 20, 2019
  • Type of Study: Observational/Survey

• Fibromyalgia Medication Study

  • Investigator: Lesley Arnold
  • Posted Date: Nov 18, 2019
  • Type of Study: Drug

• Nrg-Hn005- Randomized Phase II And Phase III Studies Of Individualized Treatment For Nasopharyngeal Carcinoma Based On Biomarker Epstein Barr Virus (Ebv) Deoxyribonucleic Acid (Dna)

  • Investigator: Vinita Takiar
  • Posted Date: Nov 7, 2019
  • Type of Study: Drug

• Using Infographic-Based Teaching Techniques To Improve Patient Comprehension And Satisfaction & Acgme Trainees (Residents & Fellows) Satisfaction, A Back To Bedside Proposal

  • Investigator: Rafiullah Khan
  • Posted Date: Nov 7, 2019
  • Type of Study: Observational/Survey

• A Trial Of Fixed-Dose Brexpiprazole With Sertraline In The Treatment Of Post-Traumatic Stress Disorder

  • Investigator: Susan Lynn Mcelroy
  • Posted Date: Oct 30, 2019
  • Type of Study: Drug

• Characterizing Particulate Matter Exposure And Cardiac Responses Among Home Healthcare Workers

  • Investigator: Ashley Turner
  • Posted Date: Oct 30, 2019
  • Type of Study: Observational/Survey

• Is Hypotension The Mechanism Behind Cognitive Fluctuations In Parkinson’S Disease Dementia And Dementia With Lewy Bodies?

  • Investigator: Alberto Espay
  • Posted Date: Oct 29, 2019
  • Type of Study: Observational/Survey

• Ucci-Hn-19-02- Determining Hbd-3 As A Valid Biomarker In Head And Neck Cancer.

  • Investigator: Alice Tang
  • Posted Date: Oct 15, 2019
  • Type of Study: Observational/Survey

• Vb-111-70/Gog-3018- A Randomized, Controlled, Double-Arm, Double-Blind, Multi-Center Study Of Ofranergene Obadenovec (Vb-111) Combined With Paclitaxel Vs. Paclitaxel Combined With Placebo For The Treatment Of Recurrent Platinum-Resistant Ovarian Cancer

  • Investigator: Thomas Herzog
  • Posted Date: Oct 15, 2019
  • Type of Study: Drug

• Immune Related Adverse Events Following Checkpoint Inhibitors

  • Investigator: Eric Vick
  • Posted Date: Oct 14, 2019
  • Type of Study: Observational/Survey

• Long-Term Extension Safety And Efficacy Study Of Sar442168 In Participants With Relapsing Multiple Sclerosis

  • Investigator: Lawrence Goldstick
  • Posted Date: Oct 10, 2019
  • Type of Study: Drug

• A Study To Investigate The Pharmacokinetics, Safety, And Tolerability Of Subcutaneous Ocrelizumab Administration In Patients With Multiple Sclerosis (Ocarina)

  • Investigator: Lawrence Goldstick
  • Posted Date: Oct 7, 2019
  • Type of Study: Drug

• S1p Ich Ancillary Study

  • Investigator: Kyle Walsh
  • Posted Date: Oct 3, 2019
  • Type of Study: Observational/Survey

• Reflective Writing In Service Of Patients: The Narrative Medicine Experience Of Categorical Internal Medicine Residents At The University Of Cincinnati Medical Center

  • Investigator: Zeyu Xu
  • Posted Date: Oct 3, 2019
  • Type of Study: Observational/Survey

• Bl-8040.Scm.301- A Phase III, Randomized, Double-Blinded Placebo-Controlled, Multi-Centre Study Evaluating The Safety, Tolerability And Efficacy Of Combination Treatment Of Bl- 8040 And G-Csf As Compared To Placebo And G-Csf For The Mobilization Of Hemato

  • Investigator: Tahir Latif
  • Posted Date: Oct 1, 2019
  • Type of Study: Drug

• Nrg-Gi006- Phase III Randomized Trial Of Proton Beam Therapy (Pbt) Versus Intensity Modulated Photon Radiotherapy (Imrt) For The Treatment Of Esophageal Cancer

  • Investigator: Jordan Kharofa
  • Posted Date: Oct 1, 2019
  • Type of Study: Drug

• S1802- Phase III Randomized Trial Of Standard Systemic Therapy (Sst) Versus Standard Systemic Therapy Plus Definitive Treatment (Surgery Or Radiation) Of The Primary Tumor In Metastatic Prostate Cancer

  • Investigator: Abhinav Sidana
  • Posted Date: Oct 1, 2019
  • Type of Study: Drug

• Ea3163- Phase II Randomized Trial Of Neo-Adjuvant Chemotherapy Followed By Surgery And Post-Operative Radiation Versus Surgery And Post-Operative Radiation For Organ Preservation On T3 And T4a Nasal And Paranasal Sinus Squamous Cell Carcinoma (Npnscc

  • Investigator: Vinita Takiar
  • Posted Date: Oct 1, 2019
  • Type of Study: Observational/Survey

• S1801- A Phase II Randomized Study Of Adjuvant Versus Neoadjuvant Mk-3475 (Pembrolizumab) For Clinically Detectable Stage III-Iv High Risk Melanoma

  • Investigator: Rekha Chaudhary
  • Posted Date: Oct 1, 2019
  • Type of Study: Drug

• Nrg-Br004- A Randomized, Double-Blind, Phase III Trial Of Paclitaxel/Trastuzumab/Pertuzumab With Atezolizumab Or Placebo In First-Line Her2-Positive Metastatic Breast Cancer

  • Investigator: Neetu Radhakrishnan
  • Posted Date: Sep 25, 2019
  • Type of Study: Drug

• A Prospective, Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Phase 3 Study To Assess The Efficacy And Safety Of Clazosentan In Preventing Clinical Deterioration Due To Delayed Cerebral Ischemia (Dci), In Adult Subjects With A

  • Investigator: Charles Prestigiacomo
  • Posted Date: Sep 25, 2019
  • Type of Study: Drug

• Platinum Chemotherapy Vs. Capecitabine In Treating Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy

  • Investigator: Neetu Radhakrishnan
  • Posted Date: Sep 25, 2019
  • Type of Study: Drug

• A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study To Evaluate The Safety And Efficacy Of Ravulizumab In Complement-Inhibitor-Naïve Adult Patients With Generalized Myasthenia Gravis

  • Investigator: Hani Kushlaf
  • Posted Date: Sep 24, 2019
  • Type of Study: Drug

• Astral - Biogen Brain Contusion Study

  • Investigator: Laura Ngwenya
  • Posted Date: Sep 20, 2019
  • Type of Study: Drug

• Efficacy And Safety Of A Treatment For Eczema (Atopic Dermatitis)

  • Investigator: Alan Fleischer
  • Posted Date: Sep 16, 2019
  • Type of Study: Drug

• Kezar Kzr-616 For The Treatment Of Proteinuria In Patients With Lupus Nephritis

  • Investigator: Bassam Abu Jawdeh
  • Posted Date: Sep 9, 2019
  • Type of Study: Drug

• Increasing Utilization Of Deceased Donor Kidneys: Modeling Outcomes Using Kidneys From Hcv-Infected Donors For Hcv-Uninfected Recipients

  • Investigator: Mark Eckman
  • Posted Date: Sep 5, 2019
  • Type of Study: Observational/Survey

• A Prospective, Randomized, Clinical Trial To Compare Quadrivalent Recombinant Influenza Vaccine (Riv) Versus Quadrivalent Inactivated Influenza Vaccine (IIv) In Pregnant Women

  • Investigator: Emily Defranco
  • Posted Date: Sep 3, 2019
  • Type of Study: Drug

• A Study Of Ly3303560 In Participants With Early Symptomatic Alzheimer's Disease

  • Investigator: Lawrence Goldstick
  • Posted Date: Aug 27, 2019
  • Type of Study: Drug

• Efficacy And Safety Of A Medication Taken Daily At Bedtime In Patients With Fibromyalgia

  • Investigator: Lesley Arnold
  • Posted Date: Aug 15, 2019
  • Type of Study: Drug

• Ea6174- A Phase III Randomized Trial Of Comparing Adjuvant Mk-3475 (Pembrolizumab) To Standard Of Care Observation In Completely Resected Merkel Cell Carcinoma

  • Investigator: Rekha Chaudhary
  • Posted Date: Aug 8, 2019
  • Type of Study: Drug

• Clinical Outcomes Of Thyroid Cancer Patients

  • Investigator: Tammy Holm
  • Posted Date: Jul 30, 2019
  • Type of Study: Observational/Survey

• Clinical Outcomes In Indeterminate Thyroid Nodules

  • Investigator: Tammy Holm
  • Posted Date: Jul 30, 2019
  • Type of Study: Observational/Survey

• Apollo

  • Investigator: Bassam Abu Jawdeh
  • Posted Date: Jul 22, 2019
  • Type of Study: Observational/Survey

• Differences Between Trainee And Attending Perceptions On The Educational Value Of Patient Care Activities

  • Investigator: Joshua Kuethe
  • Posted Date: Jul 15, 2019
  • Type of Study: Observational/Survey

• Evaluation Of Fresh Lung Tissue After Surgical Extraction With Clinical Correlations.

  • Investigator: Julian Guitron
  • Posted Date: Jul 15, 2019
  • Type of Study: Observational/Survey

• Prevention Of Hemolytic Anemia Of The Fetus Using A Novel Intravenous Infusion

  • Investigator: Kara Markham
  • Posted Date: Jul 5, 2019
  • Type of Study: Drug

• Prevalence Of Psychiatric Illnesses In Patients Undergoing Oral And Maxillofacial Surgery Procedures In An Outpatient Setting.

  • Investigator: Payal Verma
  • Posted Date: Jul 2, 2019
  • Type of Study: Observational/Survey

• Bbi-Dsp7888-102Ci- A Phase 1B, Multicenter, Open-Label Study Of Dsp-7888 Dosing Emulsion In Combination With Immune Checkpoint Inhibitors Nivolumab Or Atezolizumab In Adult Subjects With Advanced Solid Tumors

  • Investigator: Trisha Wise-Draper
  • Posted Date: Jul 1, 2019
  • Type of Study: Drug

• Assessment Of The Use Of Photographs With Skin Biopsies

  • Investigator: Alan Fleischer
  • Posted Date: Jun 27, 2019
  • Type of Study: Observational/Survey

• Vertex Pharmaceuticals Vx18-561-101 Study In Patients With Cystic Fibrosis

  • Investigator: Maria Indihar
  • Posted Date: Jun 19, 2019
  • Type of Study: Drug

• Ucci-Pdo-18-01- Developing Patient-Derived Organold (Pdo) Models For Preclinical Testing.

  • Investigator: Trisha Wise-Draper
  • Posted Date: Jun 17, 2019
  • Type of Study: Observational/Survey

• Nrg Lu-002: Maintenance Systemic Therapy Versus Consolidative Sterotactic Body Radiation Therapy (Sbrt) Plus Maintenance Systemic Therapy For Limited Metastatic Non-Small Cell Lung Cancer (Nsclc): A Randomized Phase II/III Trial

  • Investigator: Emily Daugherty
  • Posted Date: Jun 17, 2019
  • Type of Study: Drug

• Ast-008-102- A Phase 1B/2 Study Of Ast-008 Combined With Pembrolizumab In Patients With Advanced Solid Tumors

  • Investigator: Trisha Wise-Draper
  • Posted Date: Jun 17, 2019
  • Type of Study: Drug

• Nrg-Gi003- A Phase III Randomized Trial Of Protons Versus Photons For Hepatocellular Carcinoma

  • Investigator: Jordan Kharofa
  • Posted Date: Jun 17, 2019
  • Type of Study: Observational/Survey

• Real World Study Of Safety And Tolerability Of Switching From Different Ms Drugs To Newly Approved Mayzent (Siponimod)

  • Investigator: Aram Zabeti
  • Posted Date: Jun 16, 2019
  • Type of Study: Drug

• Observation For Severe Hemolytic Anemia Of The Fetus

  • Investigator: Kara Markham
  • Posted Date: Jun 14, 2019
  • Type of Study: Observational/Survey

• The Value Of Gut Microbiota In Pulmonary Arterial Hypertension

  • Investigator: Arun Jose
  • Posted Date: Jun 13, 2019
  • Type of Study: Observational/Survey

• Non-Invasive Spinal Stimulation For The Treatment Of Major Depression

  • Investigator: Francisco Romo-Nava
  • Posted Date: Jun 12, 2019
  • Type of Study: Device

• Respiratory Tract Microbiome In Children

  • Investigator: Tiina Reponen
  • Posted Date: Jun 12, 2019
  • Type of Study: Observational/Survey

• A Randomized, Placebo-Controlled Study Of Liraglutide 3Mg Daily (Saxenda®) In Obese Or Overweight Patients With Stable Bipolar Disorder

  • Investigator: Susan Lynn Mcelroy
  • Posted Date: Jun 12, 2019
  • Type of Study: Drug

• A Study To Evaluate The Safety And Effectiveness Of A New Antiseizure Drug Called Xen1101

  • Investigator: Brian Moseley
  • Posted Date: Jun 12, 2019
  • Type of Study: Drug

• Clinical Outcomes In Endocrine Disease

  • Investigator: Tammy Holm
  • Posted Date: Jun 11, 2019
  • Type of Study: Observational/Survey

• Bio-Data-16-01 Using Novel Objective Bio-Data To Improve Quality Of Life Assessment In Patients Undergoing Cytotoxic Chemotherapy: An Interventional Pilot Study

  • Investigator: Thomas Herzog
  • Posted Date: Jun 11, 2019
  • Type of Study: Device

• D6070c00005-A Phase 1B/2 Study To Evaluate The Safety, Pharmacokinetics, And Clinical Activity Of Oleclumab (Medi9447) With Or Without Durvalumab In Combination With Chemotherapy In Subjects With Metastatic Pancreatic Ductal Adencarcinoma

  • Investigator: Olugbenga Olowokure
  • Posted Date: Jun 11, 2019
  • Type of Study: Drug

• Ucci-Hem-17-01- Feasibility And Safety Of Intrathecal Rituximab Added To Standard Intrathecal Prophylaxis To Prevent Cns Relapse For Cd 20 Positive Non Hodgkin Lymphoma

  • Investigator: Tahir Latif
  • Posted Date: Jun 11, 2019
  • Type of Study: Drug

• Randomized Controlled Trial Of Immediate Versus Delayed Cochlear Implantation Hearing Loss In Older Adults Study

  • Investigator: Ravi Samy
  • Posted Date: Jun 10, 2019
  • Type of Study: Device

• Ea1151-Tomosynthesis Mammographic Imaging Screening Trial (Tmist)

  • Investigator: Lawrence Sobel
  • Posted Date: Jun 10, 2019
  • Type of Study: Observational/Survey

• Eovist Gadoxetate Sodium Enhanced Magnetic Resonance Imaging (Mri) As A Biomarker For Aggressive Prostate Cancer

  • Investigator: Sadhna Verma
  • Posted Date: Jun 10, 2019
  • Type of Study: Device

• Ea8143- A Phase 3 Randomized Study Comparing Perioperative Nivolumab Vs. Observation In Patients With Localized Renal Cell Carcinoma Undergoing Nephrectomy (Prosper Rcc)

  • Investigator: Abhinav Sidana
  • Posted Date: Jun 10, 2019
  • Type of Study: Drug

• Alliance A221505 Phase III Randomized Trial Of Hypofractionated Post Mastectomy Radiation With Breast Reconstruction.

  • Investigator: Teresa Meier
  • Posted Date: Jun 10, 2019
  • Type of Study: Observational/Survey

• 2015-7950R Multiparametric Mri's Detection Of Clinically Significant Prostate Cancer

  • Investigator: Sadhna Verma
  • Posted Date: Jun 10, 2019
  • Type of Study: Observational/Survey

• Cg01-Gbm Standard Chemotherapy Versus Chemotherapy Chosen By Cancer Stem Cell Chemosensitivity Testing In The Management Of Patients With Recurrent Glioblastoma Multiforme (Gbm).

  • Investigator: Soma Sengupta
  • Posted Date: Jun 10, 2019
  • Type of Study: Observational/Survey

• Isa101b-Hn-01-17 A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study Of Cemiplimab Versus The Combination Of Cemipilmab With Isa101b In The Treatment Of Subjects With Hpv16-Positive Platin-Resistant Oropharyngeal Cancer (Opc)

  • Investigator: Muhammad Riaz
  • Posted Date: Jun 10, 2019
  • Type of Study: Drug

• Nrg-Gy006-A Randomized Phase II Trial Of Radiation Therapy And Cisplatin Alone Or In Combination With Intravenous Triapine In Women With Newly Diagnosed Bulky Stage Ib2, Stage II, IIIb, Or Iva Cancer Of The Uterine Cervix Or Stage II-Iva Vaginal

  • Investigator: Thomas Herzog
  • Posted Date: Jun 10, 2019
  • Type of Study: Drug

• A Prospective Registry For Patients Treated With Proton Therapy

  • Investigator: John Breneman
  • Posted Date: Jun 7, 2019
  • Type of Study: Observational/Survey

• Novel Contrast Enhanced Mri Protocol For Detecting Small Brain Tumor

  • Investigator: Jinghua Wang
  • Posted Date: Jun 6, 2019
  • Type of Study: Device

• Optimizing Magnetic Resonance Imaging Acquisitions For Brain Imaging

  • Investigator: Jinghua Wang
  • Posted Date: Jun 6, 2019
  • Type of Study: Device

• General Blood Draw To Help Develop Ways To Break Up Blood Clots

  • Investigator: Christy Holland
  • Posted Date: Jun 6, 2019
  • Type of Study: Device & Drug

• Chest Wall Injury Database

  • Investigator: Christopher Janowak
  • Posted Date: Jun 6, 2019
  • Type of Study: Observational/Survey

• Utilization Of Adjuvant Chemotherapy In Patients With Pathologic Complete Response In Rectal Cancer

  • Investigator: Ian Paquette
  • Posted Date: May 29, 2019
  • Type of Study: Observational/Survey

• Ship- A Randomized, Placebo-Controlled Pilot Study Of Sulfasalazine For The Treatment Of Primary Sclerosing Cholangitis

  • Investigator: Kenneth Sherman
  • Posted Date: May 23, 2019
  • Type of Study: Drug

• Subcutaneous Pain Medication To Provide Faster Pain Relief During A Sickle Cell Crisis

  • Investigator: Caroline Freiermuth
  • Posted Date: May 23, 2019
  • Type of Study: Observational/Survey

• Epidemiology Of Subdural Hematomas At The University Of Cincinnati Medical Center

  • Investigator: David Robinson
  • Posted Date: May 22, 2019
  • Type of Study: Observational/Survey

• Ucci-Hn-17-02 An Open-Label, Phase II Study Of Durvalumab (Medi4736) In Combination With Cetuximab In Previously Treated Recurrent Or Metastatic Head And Neck Squamous Cell Carcinoma (Hnscc)

  • Investigator: Shuchi Gulati
  • Posted Date: May 20, 2019
  • Type of Study: Drug

• Subjects With Radioiodine-Refractory Differentiated Thyroid Cancer Who Have Progressed After Prior Vegfr-Targeted Therapy

  • Investigator: David Steward
  • Posted Date: May 17, 2019
  • Type of Study: Drug

• Trial To Validate Medication Adherence Monitoring Using Facial Recognition And Motion Sensing Technology For Patients Receiving Sublingual Buprenorphi

  • Investigator: Theresa Winhusen
  • Posted Date: May 15, 2019
  • Type of Study: Observational/Survey

• Emergency Contraceptive Study For Females Weighing 176 Pounds Or More Who Have Recently Had Unprotected Intercourse.

  • Investigator: Michael Thomas
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Healthy Goal Achievement Through Action Planning And Lifestyle Management After Stroke Intervention (Healthy Goals): An Efficacy Study.

  • Investigator: Valerie Hill
  • Posted Date: May 15, 2019
  • Type of Study: Device

• Prospective Study Of Magnetic Resonance Imaging (Mri) And Multiparameter Gene Expression Assay In Ductal Carcinoma In Situ (Dcis)

  • Investigator: Neetu Radhakrishnan
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A151216- Adjuvant Lung Cancer Enrichment Marker Identification And Sequencing Trial (Alchemist)

  • Investigator: Emily Daugherty
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Ea2165-A Randomized Phase II Study Of Nivolumab After Combined Modality Therapy (Cmt) In High Risk Anal Cancer

  • Investigator: Tahir Latif
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Randomized Phase III Trial Of Adjuvant Therapy Comparing Doxorubicin Plus Cyclophosphamide Followed By Weekly Paclitaxel With Or Without Carboplat

  • Investigator: Elizabeth Shaughnessy
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Niche Trial: Stroke Recovery Therapy Using Brain Stimulation

  • Investigator: Kari Dunning
  • Posted Date: May 15, 2019
  • Type of Study: Device

• Nrg-Hn001- Randomized Phase II And Phase III Studies Of Individualized Treatment For Nasopharyngeal Carcinoma Based On Biomarker Epstein Barr Virus (Ebv) Deoxyribonucleic Acid (Dna)

  • Investigator: Jordan Kharofa
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Testing The Effect Of Adding Abiraterone Acetate And Enzalutamide To Metastatic Hormone Refractory Prostate Cancer, When Compared To Enzalutamide Alon

  • Investigator: Nilesh Patil
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• An Open-Label, Single-Arm Study To Evaluate The Effectiveness And Safety Of Ocrelizumab In Patients With Early Stage Relapsing Remitting Multiple Scle

  • Investigator: Lawrence Goldstick
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Randomized, Placebo Controlled Phase 2B/3 Study Of Abt-414 With Concurrent Chemoradiation And Adjuvant Temozolomide In Subjects With Newly Diagnosed

  • Investigator: Rekha Chaudhary
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A 2-Year, Multi-Center, Phase II, Open-Label, Fixed-Dose, Randomized Comparative Trial Of Azacitidine, With Or Without Deferasirox In Patients With Hi

  • Investigator: Stephen Medlin
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Research In Pulmonary, Critical Care, And Sleep Medicine

  • Investigator: Francis Mccormack
  • Posted Date: May 15, 2019
  • Type of Study: Observational/Survey

• Please Contact The Coordinator For More Information.

  • Investigator: Lawrence Goldstick
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Phase II/III Study Of Image-Guided Radiosurgery/Sbrt For Localized Spine Metastasis

  • Investigator: Kevin Redmond
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Ucci-Bn-16-01- A Phase 0/1 Exploratory Pharmacokinetic And Pharmacodynamics Study Of Letrozole In Combination With Standard Therapy In Recurrent Gliomas.

  • Investigator: Trisha Wise-Draper
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Phase 2 Study To Evaluate The Safety And Effect Of Study Drug On Proteinuria In Subjects With Iga Nephropathy, Lupus Nephritis, Membranous Nephropa

  • Investigator: Mahmoud El-Khatib
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Ucci-Umb-14-01-An Investigation Of Molecular Markers, Metabolism, And The Immune System Compared To Clinical Outcomes In Cancer Patients And Normal Healthy Controls: An Umbrella Tissue Collection And Chart Review Protocol

  • Investigator: Trisha Wise-Draper
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Phase II Randomized Controlled Trial Of Genomically Directed Therapy After Preoperative Chemotherapy In Patients With Triple Negative Breast Cance

  • Investigator: Mahmoud Charif
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Randomized Phase II Pilot Study Prospectively Evaluating Treatment For Patients Based On Ercc1 (Excision Repair Cross-Complementing 1) For Advanced/

  • Investigator: John Morris
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Phase II Study Of The Selective Braf Kinase Inhibitor Gsk2118436 In Subjects With Advanced Non-Small Cell Lung Cancer And Braf Mutations

  • Investigator: John Morris
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Phase IIb Randomized, Double Blind, Comparative Study To Assess The Efficacy, Safety, Tolerability And Inhibition Of Ovulation Of Two Continuous Reg

  • Investigator: Michael Thomas
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Early Intervention In Cognitive Aging

  • Investigator: Robert Krikorian
  • Posted Date: May 15, 2019
  • Type of Study: Observational/Survey

• R1008- A Randomized Phase II Study Of Adjuvant Concurrent Radiation And Chemotherapy Versus Radiation Alone In Resected High-Risk Malignant Salivary Gland Tumors

  • Investigator: Trisha Wise-Draper
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Rrx-001-211-01- A Phase II Study Of Rrx-001 In Platinum Refractory/Resistant Small Cell Lung Cancer, Egfr Tki Resistant Egfr+ T790m Negative Non-Small Cell

  • Investigator: John Morris
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• E4512- A Phase III Double-Blind Trial For Surgically Resected Early Stage Non-Small Cell Lung Cancer: Crizotinib Versus Placebo For Patients With Tumors Harboring The Anaplastic Lymphoma Kinase (Alk) Fusion Protein

  • Investigator: Muhammad Riaz
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Traditional Versus Early Aggressive Therapy For Multiple Sclerosis (Treat-Ms) Trial

  • Investigator: Roman Kassa
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Ucci-Brain-16-01- Feasibility Study Of Modified Atkins Ketogenic Diet In The Treatment Of Newly Diagnosed Malignant Glioma

  • Investigator: Rekha Chaudhary
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• The Glycemia Reduction Approaches In Diabetes: A Comparative Effectiveness Study

  • Investigator: Robert Cohen
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Nrg-Hn004- Randomized Phase II/III Trial Of Radiotherapy With Concurrent Medi4736 (Durvalumab) Vs. Radiotherapy With Concurrent Cetuximab In Patients With Stage III-Ivb Head And Neck Cancer With A Contraindication To Cisplatin

  • Investigator: Vinita Takiar
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Child Depression Study

  • Investigator: Melissa Delbello
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Phase Ib, Open-Label, Dose Escalation Trial Investigating Different Doses And Schedules Of Sym004 In Combination With Platinum-Doublets In Subjects

  • Investigator: John Morris
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Fulvestrant Alone Versus Fulvestrant And Everolimus Versus Fulvestrant, Everolimus And Anastrozole: A Phase III Randomized Placebo-Controlled Trial I

  • Investigator: John Morris
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Enroll-Hd

  • Investigator: Andrew Duker
  • Posted Date: May 15, 2019
  • Type of Study: Observational/Survey

• A Phase III Trial Evaluating Both Erlotinib And Chemoradiation As Adjuvant Treatment For Patients With Resected Head Of Pancreas Adenocarcinoma

  • Investigator: Kevin Redmond
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Randomized Phase II Study Of Irinotecan And Cetuximab With Or Without Vemurafenib In Braf Mutant Metastatic Colorectal Cancer.

  • Investigator: John Morris
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Study To Evaluate The Effectiveness And Safety Of Ocrelizumab In Participants With Early Stage Relapsing Remitting Multiple Sclerosis (Rrms)

  • Investigator: Aram Zabeti
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Phase III Trial Of Accelerated Whole Breast Irradiation With Hypofractionation Plus Concurrent Boost Versus Standard Whole Breast Irradiation Plus S

  • Investigator: Kevin Redmond
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• International Prospective Database At The Hub

  • Investigator: Sandra Starnes
  • Posted Date: May 15, 2019
  • Type of Study: Observational/Survey

• Phase II Trial Of Smo/Akt/Nf2 Inhibitors In Progressive Meningiomas With Smo/Akt/Nf2 Mutations

  • Investigator: Rekha Chaudhary
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Randomized Phase III Study Of Sorafenib Versus Stereotatic Body Radiation Therapy Followed By Sorafenib In Hepatocellular Carcinoma

  • Investigator: Kevin Redmond
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Study Of Hsp90 Inhibitor At13387 Alone And In Combination With Crizotinib In The Treatment Of Non-Small Cell Lung Cancer (Nsclc)

  • Investigator: Nagla Abdel Karim
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Randomized, Double-Blind, Double-Dummy, Parallel-Group Study To Evaluate The Efficacy And Safety Of Ocrelizumab In Comparison To Interferon Beta-1A

  • Investigator: Aram Zabeti
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Age Related Study For Breast Cancer Survivors Comparing Treatment For Painful Intercourse.

  • Investigator: James Whiteside
  • Posted Date: May 15, 2019
  • Type of Study: Device

• A Randomized, Phase II Trial Of Intermittent Versus Continuous Dosing Of Dabrafenib (Nsc-763760) And Trametinib (Nsc-763093) In Brafv600e/K Mutant Mel

  • Investigator: John Morris
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Phase III, Open-Label, Randomized Study To Investigate The Efficacy And Safety Of Atezolizumab (Anti?Pd L1 Antibody) Compared With Best Supportive C

  • Investigator: John Morris
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Phase 2 Evaluation Of Trc105 In Combination With Bevacizumab For The Treatment Of Recurrent Or Progresisve Gliblastoma That Has Progressed On Bevaci

  • Investigator: Rekha Chaudhary
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Ms200095-0022- A Phase II Single-Arm Trial To Investigate Tepotinib In Stage IIIb/Iv Adenocarcinoma Of The Lung With Met Exon 14 (Metex14) Skipping Alterations After Failure Of At Least One Prior Active Therapy, Including A Platinum-Doublet-Containing Reg

  • Investigator: John Morris
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Preoperative Extended Chemotherapy Vs. Chemotherapy Plus Hypofractionated Radiation Therapy For Borderline Resectable Adenocarcinoma Of The Head Of Th

  • Investigator: Syed Ahmad
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Testing An Investigational Drug With Standard Treatment Before Surgery For Rectal Cancer

  • Investigator: Kevin Redmond
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Phase 3 Randomized, Multicenter, Multinational, Double-Blinded Study Comparing The Efficacy And Safety Of Repeated Biweekly Infusions Of Neogaa (Gz4

  • Investigator: Hani Kushlaf
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Randomized Double-Blind Phase 3 Trial Comparing Vintafolide (Ec145) And Pegylated Liposomal Doxorubicin (Pld/Doxil?/Caelyx?) In Combination Versus P

  • Investigator: Eric Eisenhauer
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Novel Biomarker Study In Subjects With Newly Diagnosed Primary Glioblastoma Multiforme (Gbm)

  • Investigator: Rekha Chaudhary
  • Posted Date: May 15, 2019
  • Type of Study: Observational/Survey

• A Randomized Phase III Trial Of Adjuvant Therapy Comparing Chemotherapy Alone (Six Cycles Of Docetaxel Plus Cyclophosphamide Or Four Cycles Of Doxorub

  • Investigator: Elizabeth Shaughnessy
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Phase I Open-Label Study To Evaluate The Effect Of Multiple Doses Of Azd1775 On The Pharmacokinetics Of Substrates For Cyp3a, Cyp2c19, Cyp1a2 And To

  • Investigator: Trisha Wise-Draper
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Exceptional Responders Pilot Study: Molecular Profiling Of Tumors From Cancer Patients Who Are Exceptional Responders

  • Investigator: John Morris
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Anemia In End Stage Renal Disease Study Testing And Investigational Drug Daprodustat Anemia Pill Vs. The Standard Of Care (Aranesp) Injections.

  • Investigator: Shashi Kant
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Comparison Of Hemorrhagic And Ischemic Strokes Among Blacks And Whites: A Population-Based Study In Greater Cincinnati, Ohio

  • Investigator: Brett Kissela
  • Posted Date: May 15, 2019
  • Type of Study: Observational/Survey

• Nrg-Bn003- Phase III Trial Of Observation Versus Irradiation For A Gross Totally Resected Grade II Meningioma

  • Investigator: Kyle Wang
  • Posted Date: May 15, 2019
  • Type of Study: Observational/Survey

• High-Intensity Interval Training In Chronic Stroke

  • Investigator: Kari Dunning
  • Posted Date: May 15, 2019
  • Type of Study: Observational/Survey

• A Phase 1B, Open Label Study Of Dalantercept Plus Sorafenib In Patients With Advanced Hepatocellular Carcinoma

  • Investigator: Olugbenga Olowokure
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Ucci-Gi-16-01- A Prospective Pilot Study To Evaluate The Feasibility Of Intensity Modulated Proton Therapy In Reducing Toxicity In Anal Cancer

  • Investigator: Jordan Kharofa
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Pragmatic Phase III Randomized Trial Of Proton Vs. Photon Therapy For Patients With Non-Metastatic Breast Cancer Receiving Comprehensive Nodal Radiati

  • Investigator: Teresa Meier
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Gemcitabine/Abraxane Chemotherapy And Dose Escalated Radiotherapy For Locally Advanced, Unresectable Pancreatic Cancer

  • Investigator: Olugbenga Olowokure
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Phase 2/3, Multi-Center, Open-Label, Randomized Study Of Weekly Nab?- Paclitaxel In Combination With Gemcitabine Or Carboplatin, Compared To Gemcita

  • Investigator: Mahmoud Charif
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Phase III Randomized Study Of Oral Sapacitabine In Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia

  • Investigator: Stephen Medlin
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Study To Evaluate The Clinical Efficacy And Safety Of Subcutaneous Administration Of An Investigational Drug In The Prophylactic Treatment Of Heredita

  • Investigator: Jonathan Bernstein
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Adhd Study For Children And Adolescents

  • Investigator: Melissa Delbello
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Do You Have Depression And Have Tried Antidepressant Medication?

  • Investigator: Lesley Arnold
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Patient Assisted Intervention For Neuropathy: Comparison Of Treatment In Real Life Situations (Pain-Controls)

  • Investigator: Hani Kushlaf
  • Posted Date: May 15, 2019
  • Type of Study: Observational/Survey

• A Multicenter, Double-Blind, Parallel-Arm, Placebo-Controlled, Phase 2 Study Of The Efficacy, Safety, And Tolerability Of Oral Full-Spectrum Microbiot

  • Investigator: Bruce Yacyshyn
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Cervical Diverticulum Prospective, Multi-Institutional Study Proposal

  • Investigator: Rebecca Howell
  • Posted Date: May 15, 2019
  • Type of Study: Observational/Survey

• Maternal Outcomes And Neurodevelopmental Effects Of Antiepileptic Drugs (Monead)

  • Investigator: Jennifer Cavitt
  • Posted Date: May 15, 2019
  • Type of Study: Observational/Survey

• A Randomized, Double-Blinded, Placebo-Controlled Phase II Study Of Adjuvant Everolimus Following The Resection Of Metastatic Pancreatic Neuroendocrine

  • Investigator: Shimul Shah
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Nrg-Gu006- A Phase II, Double-Blinded, Placebo-Controlled Randomized Trial Of Salvage Radiotherapy With Or Without Enhanced Anti-Androgen Therapy With Apalutamide In Recurrent Prostate Cancer.

  • Investigator: Timothy Struve
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Nrg-Gi004- Colorectal Cancer Metastatic Dmmr Immuno-Therapy (Commit) Study: A Randomized Phase III Study Of Mfolfox6/Bevacizumab Combination Chemotherapy With Or Without Atezolizumab Or Atexolizumab Monotherapy In The First-Line Treatment Of Patients With

  • Investigator: Jordan Kharofa
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Assessment Of Dha On Reducing Early Preterm Birth

  • Investigator: Emily Defranco
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Inflammation Biomarkers And Treatment Outcome In Complex Regional Pain Syndrome

  • Investigator: Harsh Sachdeva
  • Posted Date: May 15, 2019
  • Type of Study: Observational/Survey

• A081105- Randomized Study Of Erlotinib Vs Observation In Patients With Completely Resected Epidermal Growth Factor Receptor (Egfr) Mutant Non-Small Cell Lung Cancer (Nscls)

  • Investigator: Muhammad Riaz
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Post Market Surveillance Study Of The Wingspan? Stent System With Gateway? Percutaneous Transluminal Angioplasty (Pta) Balloon Catheter, Also Known

  • Investigator: Andrew Ringer
  • Posted Date: May 15, 2019
  • Type of Study: Observational/Survey

• A Study Of The Contraceptive Efficacy, Safety And Tolerability Of The Ag200-15 Transdermal Contraceptive Delivery System (Birth Control Patch).

  • Investigator: Michael Thomas
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Phase 3, Double-Blind, Placebo-Controlled, Randomized, Multi-Center Study To Evaluate The Safety And Efficacy Of Estradiol In Combination With Proge

  • Investigator: Michael Thomas
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Phase III Randomized, Double Blind Trial Of Chemoembolization With Or Without Sorafenib In Unresectable Hepatocellular Carcinoma (Hcc) In Patients W

  • Investigator: Olugbenga Olowokure
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Ucci-Hn-17-01

  • Investigator: Trisha Wise-Draper
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Phase II Double-Blinded Placebo-Controlled Study Of Bevacizumab With Or Without Amg 386 In Patients With Recurrent Glioblastoma Or Gliosarcoma.

  • Investigator: Kevin Redmond
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating The Use Of Adjuvant Endocrine Therapy +/- One Year Of Everolimus In Patients With H

  • Investigator: Mahmoud Charif
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Study To Evaluate The Safety And Effectiveness Of Evicel? Fibrin Sealant Compared To A Hydrogel Sealant For Sutured Dural Repair

  • Investigator: Norberto Andaluz
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Randomized Double-Blind Phase III Study Of Ibrutinib During And Following Autologous Stem Cell Transplantation Versus Placebo In Patients With Relap

  • Investigator: Tahir Latif
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Identification Of A Plasma Proteomic Signature For Lung Cancer

  • Investigator: Sandra Starnes
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Study Of Arn-509 In Men With Non-Metastatic (M0) Castration-Resistant Prostate

  • Investigator: R. Bruce Bracken
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Long Term Safety Study Of Amifampridine Phosphate In Patients With Musk Antibody Positive And Achr Antibody Positive Myasthenia Gravis Patients

  • Investigator: Hani Kushlaf
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Ea2142- Randomized Phase II Study Of Platinum And Etoposide Versus Temozolomide And Capecitabine In Patients With Advanced G3 Non-Small Cell Gastroenteropancreatic Neuroendocrine Carcinomas

  • Investigator: Olugbenga Olowokure
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Stu022015-069 A Randomized Phase III Study Of Sublobar Resection (Sr) Versus Stereotactic Ablative Radiotherapy (Sabr) In High Risk Patients With Stage I Non-Small Cell Lung Cancer (Nsclc)

  • Investigator: Sandra Starnes
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Phase III Randomized Trial Of Blinatumomab For Newly Diagnosed Bcr-Abl Negative B Lineage Acute Lymphoblastic Leukemia In Adults

  • Investigator: Stephen Medlin
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• The Milo Study (Mek Inhibitor In Low-Grade Serous Ovarian Cancer): A Multinational, Randomized, Open-Label Phase 3 Study Of Mek162 Vs. Physician’S Choice Of Chemotherapy In Patients With Recurrent Or Persistent Low-Grade Serous Carcinomas Of The Ovary, Fallopian Tube Or Primary Peritoneum

  • Investigator: Eric Eisenhauer
  • Posted Date: Mar 10, 2014
  • Type of Study: Drug